Mitchell Shawnte 4
4 · Olema Pharmaceuticals, Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Mitchell Shawnte
CHIEF LEGAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2026-03-03$4.37/sh+15,000$65,550→ 15,000 total - Sale
Common Stock
[F1]2026-03-03$23.01/sh−15,000$345,150→ 0 total - Exercise/Conversion
Common Stock
2026-03-04$4.37/sh+25,000$109,250→ 25,000 total - Sale
Common Stock
[F2]2026-03-04$24.25/sh−24,767$600,600→ 233 total - Sale
Comon Stock
[F3]2026-03-04$24.69/sh−233$5,753→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-03-03−15,000→ 435,000 totalExercise: $4.37Exp: 2035-02-27→ Common Stock (15,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-03-04−25,000→ 410,000 totalExercise: $4.37Exp: 2035-02-27→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]The weighted average sale price for the transaction reported was $23.01, and the range of prices were between $22.89 and $23.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F2]The weighted average sale price for the transaction reported was $24.25, and the range of prices were between $23.68 and $24.64. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $24.69, and the range of prices were between $24.68 and $24.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Signature
/s/ Shawnte Mitchell|2026-03-05